Market Intelligence and Reports

The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is…

For product managers, market insight leaders, marketing teams, and business development professionals, knowing how scientists experience your brand, and how that experience stacks up against key competitors, is essential for prioritizing investment, sharpening positioning, and uncovering growth opportunities. As life science researchers continue to elevate their experience expectations, suppliers need an objective, external view of…

SDi’s 2026 Laboratory Automation Markets report analyzes automation technologies, suppliers, and market dynamics across liquid handling, robotics, informatics, and biorepository systems in laboratories worldwide.

Kalorama’s World Market for Clinical Sequencing and Sequencing-Based IVD Products, 2026 analyzes clinical sequencing instruments, consumables, software, and diagnostic products, with forecasts through 2030.

The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.

Kalorama’s 2026 report analyzes the global mass spectrometry market in IVD, forecasting nearly double growth by 2030 across instruments, IVD kits, and clinical diagnostic applications.

The world runs on roughly 150 billion diagnostic tests a year—and that number is climbing faster than the revenue behind it. IVD Test Procedure Volumes, 8th Edition quantifies that divergence with precision, tracking global procedure volumes segment by segment and region by region as the diagnostics industry completes its transition out of the pandemic era.…

SDi’s Market Landscape: Sequencing report analyzes the sequencing market’s sizing, five-year forecasts, vendor shares, and the litigation and regulatory trends shaping Illumina, Oxford Nanopore, PacBio, and emerging entrants.

Kalorama’s 105-page clinical proteomics report sizes the market by technology and region through 2030, covering mass spectrometry, high-plex affinity assays, digital immunoassays, and spatial proteomics, with company profiles of 16 vendors and analysis of deals, approvals, and trends from 2021 to 2026.

SDi’s 2026 report covers the global analytical and life science instrumentation service market across 10 technology segments, five service categories, and key end-market sectors, with five-year forecasts through 2030 and insights from 323 laboratory professionals.

SDi’s 2026 sample preparation report covers nucleic acid prep, extraction techniques, and preparative chromatography across 15-plus segments, with market sizing, five-year forecasts through 2030, vendor market shares, and segmentation by sector, region, and application.

Now in its 11th edition, Kalorama Information’s flagship review of clinical laboratory services gives decision-makers a rigorous, independent read on where diagnostic testing revenue sits today and where it is heading. Built on a 2025 base year, with historical data spanning 2020–2024 and forecasts running through 2030, the report is the reference stakeholders use to…